medline.ch Respirationstrakt Neoplasie

	Association of Spirometric Lung Age with Survival Outcomes in Elderly Patients Undergoing Radical Surgery for Gastric Cancer. J Gastrointest Cancer Urabe M, Suzuki M, Fukai T, Hasegawa Y, Terai E, Kiya Y, Morizono G, Hiyoshi M, Watanabe T, Hashiguchi Y. PMID: 41269479 [PubMed - indexed for MEDLINE]
	Effectiveness of Shuanghuang Yangxue Decoction for Treating Cancer-Related Anemia With Serum Iron Deficiency in Lung Cancer Patients: A Randomized Clinical Trial. Integr Cancer Ther Li QY, Yang WX, Lu Y, Lin D, Mu H, Wang Q, Yao JL, Liu H, Yao LQ, Li X, Qiu WC, Xue PP, Qian C, Xu L, Shi J. PMID: 41268973 [PubMed - indexed for MEDLINE]
	Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study. Future Oncol Sands J, Ahn MJ. PMID: 41268710 [PubMed - as supplied by publisher]
	Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort study. Ann Med Guo W, Zhou B, Huai Q, Ji Y, Chen Y, He H, Han L, Li B, Zhou J, Tan F, Xue Q, Gao S, He J. PMID: 41268684 [PubMed - indexed for MEDLINE]
	Treatment-Related Adverse Events of Antibody-Drug Conjugate Monotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Thorac Cancer Li Y, Zhou L, Li S, Zhou S, Chen Y, Tong Y, Sun J, Wang L, Fan Y. PMID: 41268683 [PubMed - indexed for MEDLINE]
	Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer. Future Oncol Althoff FC, Acker F, Koschade S, Heinzen S, Aguinarte L, Rost M, Schulte H, Rohde G, Winter M, Schreiner W, Krause K, Grünwald V, Serve H, Oellerich T, Sebastian M. PMID: 41268635 [PubMed - as supplied by publisher]
	Identifying risk factors for refractory tyrosine kinase inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer. Chin Clin Oncol Huang W, Ye H, Zhu Y, Huang M, Du S, Tan P. PMID: 41268624 [PubMed - as supplied by publisher]
	Role of the SOX family in nonâ€‘small cell lung cancer: Molecular mechanisms and therapeutic implications (Review). Oncol Rep Wang K, Li Y, Guo Z, Song L, Ding X, Liu L, Hu T, Bian Y, Huang C, Miao L. PMID: 41268614 [PubMed - indexed for MEDLINE]
	Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy. Front Immunol Shi X, Deng W, Pan Y, Chen Y, Wang Y, Wu J. PMID: 41268560 [PubMed - indexed for MEDLINE]
	Advancements in extensive-stage small cell lung cancer therapy: from molecular profiling to the advent of precision oncology. Front Immunol Yang C, Shao Y, Zhang Y, Zhang H, Zhao Y. PMID: 41268540 [PubMed - indexed for MEDLINE]
	Gut microbiota and metabolites: emerging prospects in the treatment of non-small cell lung cancer. Front Immunol Jiao JM, Liu CG, Zang D, Chen J. PMID: 41268538 [PubMed - indexed for MEDLINE]
	Peripheral blood neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index values as prognostic predictors for non-small cell lung carcinoma. Am J Transl Res Liu Q, Hu Y, Li Y, Qian H, Shi D, Ji L. PMID: 41268285 [PubMed]
	Efficacy and quality of life benefits of dexamethasone in advanced non-small cell lung cancer. Am J Transl Res Liu G, Ding H, Pu T, Wang L. PMID: 41268276 [PubMed]
	Relationship between systemic immune-inflammation index and all-cause mortality in stages IIIB-IV epidermal growth factor receptor-mutated lung adenocarcinoma. Front Endocrinol (Lausanne) Zhang C, Yang C. PMID: 41268168 [PubMed - indexed for MEDLINE]
	Metabolome-Wide Mendelian Randomization Identifies Maleate as a Mediator of the Effect of Obesity on the Risk of Small Cell Lung Cancer. Food Sci Nutr Li K, Yang Z, Li H, Yan C. PMID: 41268093 [PubMed]
	Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis. Front Oncol Zhang H, Liu Y, Cai B, Wang M, Li H, Wang H. PMID: 41267974 [PubMed]
	The Efficacy and Safety of Anlotinib Treatment for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Who Achieved Stable Disease (SD) After Two Cycles of First-Line Chemotherapy Combined with Immunotherapy: A Retrospective Cohort Study. Cancer Manag Res Wu D, Liu K, Peng Y, Liu Y, Tang J, Lin X, Li X. PMID: 41267891 [PubMed]
	'Is it my last Christmas?' Using real-world data as a prompt to reflect on goal-concordant advanced lung cancer care-a retrospective, longitudinal study. BJC Rep Forrest C, Twomey J, Qayoumi M, Bryan A, Collins DC, Noonan S, Dennehy K, Gaynor S, O'Dea P, O'Sullivan H, O'Reilly S. PMID: 41266597 [PubMed]
	MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer. NPJ Precis Oncol Tsao MS, Sholl L, Shiller M, Illei P, Wistuba II, Beasley MB, Schalper KA, Simmons A, Ansell P, Beruti S, Mino-Kenudson M. PMID: 41266553 [PubMed]
	Targeting the Powerhouse: A Critical Review of Mitochondrial Inhibitors as a Therapeutic Strategy in Lung Cancer. Eur J Pharmacol Park WH. PMID: 41265621 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 154239

Seite 1 von 7712



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung